Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

As the COVID-19 pandemic wears on, newer variants of SARS-CoV-2 have been evolving ways to evade the antibodies our bodies make.

Researchers studied antibody-mediated neutralization of SARS-CoV-2 variants following a fourth vaccination with different vaccine boosters.

The emergence of SARS-CoV-2 in late 2019 and the subsequent global COVID-19 pandemic has led to substantial morbidity and mortality.

Preserving and restoring natural habitats could prevent pathogens that originate in wildlife from spilling over into domesticated animals.

Researchers have developed a technology that could significantly increase the speed and volume of disease testing, while reducing the costs.

Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists

Paper details the efficacy of H84T-BanLec against all known human-infecting coronaviruses, including MERS, the original SARS, and SARS-CoV-2

Johns Hopkins Medicine study suggests small molecule inhibitor RK-33 can block multiple variants of the SARS-CoV-2 virus from replicating.

Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system.

A Texas teenager was awarded tens of thousands of dollars for developing a potential cure for COVID-19.

The university said it hoped to start product development of the testing device in early 2021 and have an approved device available